🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Airway microbiota pattern may related the preschool asthma exacerbation. Th...
Status
Completed
Location
Children's Hospital of Fudan University
Start Date
2021-10-18
Trial ID
NCT04527016
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of com...
Status
Completed
Location
Altana Pharma/Nycomed
Start Date
2005-01
Trial ID
NCT00163488
Treatments Being Tested
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
Relatively little information is available about the effects of salmeterol/...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11
Trial ID
NCT00549146
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
The primary objective of the trial is to evaluate the efficacy of fluticaso...
Status
Recruiting
Location
Teva Investigational Site 12087
Start Date
2024-12-12
Trial ID
NCT06664619
This study is to find out if an Extra Virgin Olive-Oil-based Water (EVOOW) ...
Status
Not Yet Recruiting
Location
University of Wisconsin
Start Date
2026-08
Trial ID
NCT07664527
Treatments Being Tested
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
The purpose of this study is to assess whether the risk of serious asthma-r...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-17
Trial ID
NCT01462344
Treatments Being Tested
This will be a multi-center, randomized, placebo-controlled parallel-group ...
Status
Completed
Location
Greenville Pharmaceutical research, Inc.
Start Date
2012-03
Trial ID
NCT01516073
Treatments Being Tested